Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Trade Margin Capping by Delhi Govt: Industry Body demands Wider Consultation

      Trade Margin Capping by Delhi Govt: Industry Body demands Wider Consultation

      Medical Dialogues Bureau8 May 2018 11:27 AM IST
      New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
      India Inc invests over USD 4 billion in South Africa

      India Inc invests over USD 4 billion in South Africa

      Medical Dialogues Bureau8 May 2018 11:24 AM IST
      NEW DELHI: As many as 140 Indian companies with operations in South Africa have invested more than USD 4 billion and created 18,000 direct jobs,...
      Suven Life Sciences Pashamylaram facility successfully completes USFDA inspection

      Suven Life Sciences Pashamylaram facility successfully completes USFDA inspection

      Medical Dialogues Bureau8 May 2018 11:09 AM IST
      NEW DELHI: Drug firm Suven Life Sciences today said its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health...
      Latest bid for Indias Fortis more risky, says Manipal CEO

      Latest bid for India's Fortis "more risky", says Manipal CEO

      Medical Dialogues Bureau8 May 2018 11:09 AM IST
      India's privately held Manipal Hospitals had to take a "more risky" approach in its latest bid for domestic rival Fortis Healthcare to see off rival...
      India signs up for USD 200-million loan from World Bank for nutrition mission

      India signs up for USD 200-million loan from World Bank for nutrition mission

      Medical Dialogues Bureau8 May 2018 9:50 AM IST
      New Delhi: India signed an agreement with the World Bank on Monday for a USD 200-million loan for the National Nutrition Mission (POSHAN Abhiyaan) to...
      Zydus Cadila gets USFDA nod for anesthesia drug

      Zydus Cadila gets USFDA nod for anesthesia drug

      Medical Dialogues Bureau7 May 2018 11:47 AM IST
      Drug firm Zydus Cadila today said it has received an approval from the US health regulator to market Succinylcholine Chloride injection, used as part...
      Marksans Pharma arm recalls unspecified number of Ibuprofen tablets from US

      Marksans Pharma arm recalls unspecified number of Ibuprofen tablets from US

      Medical Dialogues Bureau7 May 2018 11:46 AM IST
      New Delhi: Marksans Pharma's arm Time-Cap Laboratories Inc is withdrawing unspecified number of Ibuprofen tablets, manufactured in Goa, in multiple...
      TPG-Backed Manipal Revises Bid for Fortis

      TPG-Backed Manipal Revises Bid for Fortis

      Medical Dialogues Bureau7 May 2018 11:44 AM IST
      (Bloomberg Report)- Fortis Healthcare Ltd. received a revised takeover offer from its first suitor, an Indian company backed by private equity firm...
      Fortis shareholders approve acquisition of RHT Health Trust assets

      Fortis shareholders approve acquisition of RHT Health Trust assets

      Medical Dialogues Bureau7 May 2018 9:39 AM IST
      Fortis Healthcare today said its shareholders have approved a resolution to acquire assets of RHT Health Trust.In a regulatory filing, the company...
      HC asks govt to set up panel to check adverse drug reactions

      HC asks govt to set up panel to check adverse drug reactions

      Medical Dialogues Bureau3 May 2018 10:15 AM IST
      Mumbai: Taking note of the increasing number of adverse drug reaction cases in civic-run hospitals, the Bombay High Court has directed the...
      Merck Foundation, MAHE to train embryologists from Asia, Africa

      Merck Foundation, MAHE to train embryologists from Asia, Africa

      Medical Dialogues Bureau2 May 2018 9:30 AM IST
      Manipal: Merck Foundation, the philanthropic arm of Merck KGaA, Germany, and Manipal Academy of Higher Education or MAHE signed a memorandum of...
      Medical studies in humans often launched on faulty evidence base: Report

      Medical studies in humans often launched on faulty evidence base: Report

      Medical Dialogues Bureau8 April 2018 8:07 PM IST
      New research reveals serious flaws in the animal studies that regulators and ethicists use to decide if an experimental drug should be tested in...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok